AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Identification and Verification of MSM Key Influencers During Secondary Distribution of HIV Self-Testing: A Machine Ensemble Learning-based Quasi-Experimental StudyView Abstract
RKJTRayner Kay Jin TanPhDVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Digital Qualitative Methods - Rayner Kay Jin Tan, BSocSc, PhDView Video
JTJoseph TuckerMD, PhD, AMVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Digital Trials- Joseph Tucker, MD, PhD, AMView Video
DWDan WuPhD, MSc, MBBSVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Digital Community Engagemnt - Dan Wu, PhD, MSc, MBBSView Video
SLSharon LewinAO, FRACP, PhD, FAHMSVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Update on COVID-19 Vaccines - What’s Available and What's the Future - Sharon Lewin, AO, FRACP, PhDView Video
RKJTRayner Kay Jin TanPhDVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Review of Digital Research Methods - Rayner Kay Jin Tan, BSocSc, PhDView Video
DWDan WuPhD, MSc, MBBSVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021The Rise of Digital - Dan Wu, PhD, MSc, MBBSView Video
TPThanyawee PuthanakitMD, MHSVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Applying for Research Funding: Where to Start and How to Think About the Process -T. Puthanakit, MDView Video
KPSKasha Priya SinghMBBS, MPH, FRACPVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021What Not to Do. Common Mistakes in Grant Writing - Kasha Priya Singh, MBBS, MPH, FRACPView Video
WJWatsamon JantarabenjakulMD, PhDVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Clinical Trial Implementation - Watsamon Jantarabenjakul, MD, PhDView Video
NPNicholas PatonMD, FRCPVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Clinical Trial Preparation - Nicholas Paton, MD, FRCPView Video
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfected Patients Through 96 WeeksView Abstract
